Status : PERMANENT FULL TIME
University Health Network (UHN) is looking for an experienced professional to fill the key role of in our Drug Development Program.
Transforming lives and communities through excellence in care, discovery and learning.
The University Health Network, where above all else the needs of patients come first , encompasses Toronto Rehabilitation Institute, Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre and the Michener Institute of Education at UHN .
The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education.
With a long tradition of groundbreaking firsts and a purpose of Transforming lives and communities through excellence in care, discovery and learning , the University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers.
UHN is a caring, creative place where amazing people are amazing the world.
University Health Network (UHN) is a research hospital affiliated with the University of Toronto and a member of the Toronto Academic Health Science Network.
The scope of research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care.
Research across UHN's five research institutes spans the full spectrum of diseases and disciplines, including cancer, cardiovascular sciences, transplantation, neural and sensory sciences, musculoskeletal health, rehabilitation sciences, and community and population health. .
The Drug Development Program at Princess Margaret Hospital is the largest drug development program in Canada and the only centre outside of the United States to have a contract with the National Institutes of Health (NIH) for Early Phase Therapeutic studies.
The Drug Development Program includes a Phase I program, focusing on studies of innovative drugs and immunotherapy, with a strong emphasis on pharmacokinetics and correlative studies.
It involves a collaborative and multidisciplinary approach and is strategically designed to ensure the rapid completion of high quality studies.
The Clinical Data Coordinator participates in the coordination of clinical trials from protocol review and approval through to activation, follow up and trial closure.
Principal responsibilities include monitoring and promoting the quality and integrity of data and recording clinical trial data in case report forms (CRF’s).
The coordination and monitoring of data is performed in accordance with the trial protocol, hospital and departmental guidelines and professional standards of practice.
Data is assessed, compiled, recorded and submitted to cooperative groups and / or pharmaceutical companies or used for internal PMH studies.
All data must be complete, accurate, timely and must be in compliance with applicable ICH-GCP, FDA and US federal code and Tri-
Council regulations. The Clinical Data Coordinator must be able to interpret the applicable regulations in order to ensure compliance.
Quality assurance procedures are utilized to ensure high quality data is obtained.
If you are interested in making your contribution at UHN, please apply on-line. You will be asked to copy and paste as well as attach your resume and covering letter.
You will also be required to complete some initial screening questions.